Wednesday, February 10, 2010, 10:21pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Caliper Life Sciences, Inc. (CALP)

At 4:59AM SGT: 3.15 USD   0.00 (0.00%)  
 MORE ON CALP 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Caliper Life Sciences Inc (NGM:CALP) Delayed quote dataEdit
Last Trade:3.15 USD
Trade Time:4:59AM SGT
Change: 0.00 (0.00%)
Prev Close:3.15
Open:N/A
Bid:2.67 x 100
Ask:3.62 x 100
1y Target Est:3.00
Day's Range:N/A - N/A
52wk Range:0.76 - 3.60
Volume:0
Avg Vol (3m):64,336.5
Market Cap:154.45M
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add CALP to Portfolio   Download Data

 HEADLINES 
•RBC Capital Markets Expert Equity Analyst Sees "Shopping Spree" For Acquisitions Of Home Health Care And Diagnostics Companies In 2010 To 2011 Time Frame
Wall Street Transcript (Wed, Feb 3)
•Caliper Life Sciences Introduces Sciclone(R) G3 Liquid Handler
PR Newswire (Mon, Jan 25)
•Caliper Integrated Robotic System Featured in TIME Magazine's Top 10 Scientific Discoveries of 2009
PR Newswire (Thu, Jan 21)
•LaBranche, Caliper Life Sciences: Biggest Price Gainers (LAB, CALP)
at The Wall Street Journal Online (Fri, Jan 15)
•[$$] Waiting On Intel
at RealMoney by TheStreet.com (Fri, Jan 15)
•CALIPER LIFE SCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure
EDGAR Online (Thu, Jan 14)
•Caliper Life Sciences Announces Preliminary Results for the Fourth Quarter and 2009
PR Newswire (Thu, Jan 14)
•Caliper Licenses Microfluidics IP to Becton Dickinson
PR Newswire (Mon, Jan 11)
•Caliper Life Sciences to Present at the 28th Annual J.P. Morgan Healthcare Conference
PR Newswire (Wed, Jan 6)
•CALIPER LIFE SCIENCES INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off
EDGAR Online (Fri, Dec 18)
More Headlines for CALP...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.18
EPS Est (in 2 years) (Dec-10) :-0.11
Avg Rec (current)*:1.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Caliper Life Sciences, Inc. develops and sells products and services to pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices